Medicare & Medicaid News for Senior Citizens

Medicare & Medicaid News

Medicare project aims at better results at less cost for drug program

It is Part D Enhanced Medication Therapy Management (Enhanced MTM)

Medicare Annual Election Period Opens Oct. 15Oct. 6, 2015 - An effort to improve medication therapy among Medicare beneficiaries enrolled in the Part D prescription drug program has been announced by the Center for Medicare and Medicaid Innovation (CMMI) of the Centers for Medicare & Medicaid Services (CMS). The hope is better health care and better patient outcomes at a lower overall health care cost.

The Part D Enhanced Medication Therapy Management (Enhanced MTM) model will assess whether providing selected Medicare Prescription Drug Plans (PDPs) with additional incentives and flexibilities to design and implement innovative programs will better achieve the overall goals for MTM programs, including:

         improving compliance with medication protocols, including high-cost drugs, ensuring that beneficiaries get the medications they need, and they are used properly;

         reducing medication-related problems, such as duplicative or harmful prescription drugs, or suboptimal treatments;

         increasing patients’ knowledge of their medications to better achieve their or their prescribers’ goals of therapy; and

         improving communication among prescribers, pharmacists, caregivers and patients.

“As part of our approach to building a health care delivery system that results in better care, smarter, spending and healthier people, CMS will test changes to the Part D program to give prescription drug plans stronger incentives and flexibility to improve prescription drug safety and efficacy,” said Patrick Conway, M.D., MSc, CMS acting principal deputy administrator and chief medical officer.

“Through this model, we are hopeful that Part D plans will invest in medication therapy management and identify new, effective strategies to optimize medication use and improve care coordination in Medicare.”

The Enhanced MTM model test will begin January 1, 2017 with a five-year performance period.   CMS will test the model in 5 Part D regions:  

         Region 7 (Virginia)

         Region 11 (Florida),

         Region 21 (Louisiana),

         Region 25 (Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota, Wyoming), and

         Region 28 (Arizona).  

Eligible stand-alone PDPs in these regions can apply to vary the intensity and types of MTM interventions they offer based on beneficiary risk level and seek out a range of strategies to individualize beneficiary outreach and engagement.

CMS will waive current MTM program requirements for participating plans in the test regions during the performance period.

Participating plans, which are limited to plans offering a basic benefit, are expected to work closely with their network pharmacy providers and local prescribers to accurately identify enrollees whose medication usage has caused, or is likely to cause, adverse outcomes and/or significant non-drug program costs. Beneficiaries who are identified will be contacted by their drug plans, pharmacists, or prescribers and offered targeted assistance in order to optimize medication use and avoid any medication-related problems.

More information about the Enhanced MTM model test can be found in the model announcement.

Webinar on Enhanced MTM

Please also save the date for a webinar on the Enhanced MTM model test, to be held on October 21, 2015. Registration information will be available on the same site.

CMS will accept applications for the Enhanced MTM via a Request for Applications (RFA), to be released shortly.  Once released, application materials will be available at: http://innovation.cms.gov/initiatives/enhancedmtm/.

 

Medicare Annual Election Period Opens Oct. 15Related Medicare & Medicaid News - Senior Journal Archives

Medicare news for seniors all good as open enrollment period nears

CMS now calling this annual period for changing plans the ‘Annual Election Period’ - Sept. 22, 2015

Medicare drug program premiums expected to stay about the same in 2016

Rates threatened by high cost of specialty drugs; growth in per-enrollee spending continues to be historically low - Aug. 19, 2015

Medicare Advantage Plans to test more flexibility for seniors with chronic ills

Medicare Advantage Value-Based Insurance Design Model targets better cafe at less cost - Sept. 2, 2015

More at Medicare & Medicaid Section Page

 

 

 

 

Follow on  and 

 

Financial Relief for Volkswagen Diesel Owners

You may be eligible for money damages if you owned or leased one of these VW, Porsche or Audi vehicles.

In the major scandal of 2015, Volkswagen cheated you and the world. They rigged diesel emission controls so you, nor regulators, would know how much pollution their cars were adding to our environment.

They were caught and have reserved $7.3 billion to help "make it right" with victims.

If you owned or leased one of these vehicles, contact us now.

 Beth Janicek, Board Certified Personal Injury Attorney Janicek Law attorneys are actively pursuing these cases against VW. Do Not Wait...

Janicek Law Firm, PC

Free Consultation

(Call toll free)

1-877-795-3425 or Email

Vehicles Involved

VW Jetta (2009–2015)

VW Jetta SportWagen (2009–2014)

VW Golf (2010-2015)

VW Golf SportWagen (2015)

VW Beetle (2012–2015)

VW Passat (2012-2015)

Audi A3 (2010-2015)

VW Touareg (2009–2016)

Porsche Cayenne (2015)

Audi A6, A7, A8, Q5 Quattro (2016)

 

Keep up with the latest news for senior citizens


Click to More Senior News on the Front Page

Copyright: SeniorJournal.com